Background: Jadelle, a long acting reversible progesterone contraceptive, has been in use in our centre for over 10 years and has not been comprehensively evaluated. Objectives: To determine the acceptance, efficacy, and safety profile associated with the use of Jadelle contraceptive implant in the University of Port Harcourt Teaching hospital, Port Harcourt. Methods: This is a 10-year retrospective study of clients who accepted and used Jadelle for contraception in the university of Port Harcourt Teaching Hospital (UPTH), Port Harcourt. The case files were retrieved and information on their socio demographic profile, source of information, side effects, failures and reason for removal were extracted using a proforma. Data were filled into a spread sheet, analyzed using SPSS version 21.0 and presented in tables of frequencies and percentages. Results: Within the period under review, March 2007 to February 2017, 569 clients used Jadelle out of the 3829 women who accepted and used modern contraceptive in the UPTH. The mean age of users was 33.7 ± 4.2, 536 (94.2%) were multipara with a mean parity of 4.5 ± 3.8 while 541 (95.1%) had secondary education and above. The major side effect was irregular vaginal bleeding 36 (60.9%) while the main reason for removal of the device was expiration of method 272 (53.9%). A pregnancy was recorded during this period giving a pearl index of 0.002. Conclusion: Jadelle is a popular and a very effective means of contraception with increasing acceptance among our clients. The safety profile is high.
(1.2 billion) of this reside in Africa [1] the continent with the second highest population, after Asia. The implications of population growth for universal access to reproductive health are particularly relevant to sub-Saharan Africa, a region that has experienced rapid population growth that is projected to remain above 2 percent per year through 2030 [2] , the time period of the 2030 agenda for sustainable development. For instance, in 2015, sub-Saharan Africa failed to achieve universal reproductive health coverage, a target under Millennium Development Goals 5 aimed at improving material health [3] .
The Nigerian population forecast by 2021 is put at 210 million [4] and a current fertility rate of 5.7. With the several challenges associated with over-population such as environmental pollution, rural-urban migration, and depletion of natural resources [5] [6] , this fertility rate is worrisome. Adoption of population policies and fertility control by means of contraception is one acceptable route of controlling this population explosion [7] ; noting that in spite of the relatively high fertility and population growth rates, low uptake of family planning services has been reported in several countries in the sub-Saharan Africa, especially in West-Africa. Contraceptive prevalence in 2015 was several times as high in Northern Africa and Southern Africa (53 percent and 64 percent, respectively) as in Middle Africa (23 percent) and Western Africa (17 percent) [8] . This relatively low prevalence has been associated with several challenges inherent in the delivery of family planning services in this sub-region.
Jadelle, a long acting reversible contraceptive option, consists of 2 sealed individual silicon rods; each is 2.5 mm in diameter and 4.3 in length, containing 75 mg levonorgestrel and is licensed for use for 5 years [9] [10] . It induces anovulation and hypotrophic endometrium by suppression of oestrogen maturation of the follicles and the endometrium; and thickens the cervical mucus [9] [11] . Jadelle is highly effective, safe and acceptable [12] [13] [14] . This long acting reversible contraceptive has minimal requirement for medical follow up once inserted. However, menstrual disturbances, compliant of weight gain and requirement for trained personnel for its insertion/removal remained issues to be sorted out in a poor resource setting like ours.
It is with these challenges in mind, coupled with the absence of enough data on the experience with Jadelle usage that this study was conceived. It is hoped that with the availability of more information on Physicians' experiences on Jadelle usage, more could be done in tackling the difficulties associated with uptake of contraceptive services in our environment particularly and Nigeria in general.
Methodology
This is a retrospective descriptive study of 569 clients who accepted to use Jadelle for contraception at the UPTH family planning clinic between March 
Result
In The mean age of users was 33.7 ± 4.2, 536 (94.2%) were multipara with a mean parity of 4.5 ± 3.8 while 541 (95.1%) had secondary education and above (Table 1) . Increasingly greater number of acceptors was recorded in the later half of the study, between 2012 and 2017 ( Table 2 ). Source of information was mainly through clinic personnel 276 (48.5%) and friends and relations 233 (40.0%) while media contributed only 33 (5.8%) self referral was 27 (4.7%). The major side effect was irregular vaginal bleeding 36 (60.9%), weight gain was 3(5.1%); Table 3 . The main reason for the implant removal was expiration of method 272 (53.9%) and discontinuation due to complication was only 54 (10.3%); Table 4 . Pearl index was 0.002 from one pregnancy recorded within the period of study. Jadelle use was almost same for spacing and limiting of children (273 and 296-48% and 52% respectively).
Discussion
There were 569 (14.9%) acceptors of Jadelle out of the 3,849 women who accepted and used contraception in this centre during the study period. Other complications such as occurrence of ovarian cyst in users though common was not documented in this study but are found to be transient [25] . It is equally noted that not all complications warranted discontinuation of the device. More importantly, most of this side effects especially the relatively common one which is irregular vagina bleeding usually remits within four months in early use and also on medication [26] [27]; meaning that it is a safe means of contraception [28] [29] . More than half (56.9%) of the removal of the implant were due to expiration hence reinsertion. Its discontinuation due to complications occurred in 10.3% of users. This is however lower than 19% found in Zaria study [30] . It also support the evidence that discontinuation due to complication is higher in Implanon than in Jadelle [30] [31].
Pearl index of jadelle was 0.002 and hence it is a very effective Contraceptive [28] [29] . Generally, long acting reversible contraceptives' higher continuation rate encourages superior protection from unintended pregnancies [18] [32] [33] [34]. Forty four of the users (7.7%) were lost to follow up and must have obtained care in the other numerous primary health care centres in the city. Unlike Implanon, Jadelle is almost equally used for limiting as in spacing children (52% and 48% respectively).
In conclusion, Jadelle has amazing protection against unintended pregnancy, good safety profile, and increasing acceptance among our clients.
